Search

Your search keyword '"Karam, Sabine"' showing total 177 results
Start Over Author "Karam, Sabine"
177 results on '"Karam, Sabine"'

2. Exploring the Challenges and Limitations in Participation of Women Nephrologists in Conferences: A Pilot Study

Author

Meena, Priti, Arellano-Mendez, Denisse, Calice-Silva, Viviane, Bek, Sibel Gokcay, Tomacruz Amante, Isabelle Dominique, Yadla, Manjusha, Mohan, Krithika, Bajpai, Divya, Shankar, Mythri, Java, Anuja, Soki, Kalida, Arce-Amare, Fernanda, Luyckx, Valerie, Karam, Sabine, Meena, Priti, Arellano-Mendez, Denisse, Calice-Silva, Viviane, Bek, Sibel Gokcay, Tomacruz Amante, Isabelle Dominique, Yadla, Manjusha, Mohan, Krithika, Bajpai, Divya, Shankar, Mythri, Java, Anuja, Soki, Kalida, Arce-Amare, Fernanda, Luyckx, Valerie, and Karam, Sabine

Published
2024
Full Text
View/download PDF

3. Assessment of Glomerular Filtration Rate in Patients with Cancer: A Statement from the American Society of Onco-Nephrology

Author

Kitchlu, Abhijat, Costa E Silva, Verônica T., Anand, Shuchi, Kala, Jaya, Abudayyeh, Ala, Inker, Lesley A., Rosner, Mitchell H., Karam, Sabine, Gudsoorkar, Prakash, Gupta, Shruti, Chen, Sheldon, Klomjit, Nattawat, Leung, Nelson, Milanez, Tomaz, Motwani, Shveta S., Khalid, Sheikh B., Srinivasan, Vinay, Wanchoo, Rimda, Beumer, Jan H., Liu, Geoffrey, Tannir, Nizar M., Orchanian-Cheff, Ani, Geng, Yimin, and Herrmann, Sandra M.

Published
2024
Full Text
View/download PDF

4. Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies – Perspectives from the ASON

Author

Kitchlu, Abhijat, Costa E Silva, Verônica T., Anand, Shuchi, Kala, Jaya, Abudayyeh, Ala, Inker, Lesley A., Rosner, Mitchell H., Karam, Sabine, Gudsoorkar, Prakash, Gupta, Shruti, Chen, Sheldon, Klomjit, Nattawat, Leung, Nelson, Milanez, Tomaz, Motwani, Shveta S., Khalid, Sheikh B., Srinivasan, Vinay, Wanchoo, Rimda, Beumer, Jan H., Liu, Geoffrey, Tannir, Nizar M., Orchanian-Cheff, Ani, Geng, Yimin, and Herrmann, Sandra M.

Published
2024
Full Text
View/download PDF

13. Cancer therapy in patients with reduced kidney function.

Author

Karam, Sabine, Rosner, Mitchell H, Sprangers, Ben, Stec, Rafal, and Malyszko, Jolanta

Subjects
*RENAL replacement therapy, *IMMUNE checkpoint inhibitors, *RENAL cancer, *NEPHROTOXICOLOGY, *KIDNEY physiology
Abstract

Chronic kidney disease (CKD) and cancer constitute two major public health burdens, and both are on the rise. Moreover, the number of patients affected simultaneously by both conditions is growing. The potential nephrotoxic effect of cancer therapies is particularly important for patients with CKD, as they are also affected by several comorbidities. Therefore, administering the right therapy at the right dose for patients with decreased kidney function can represent a daunting challenge. We review in detail the renal toxicities of anticancer therapies, i.e. conventional chemotherapy, targeted therapy, immune checkpoint inhibitors and radioligand therapies, issue recommendations for patient monitoring along with guidance on when to withdraw treatment and suggest dosage guidelines for select agents in advanced stage CKD. Various electrolytes disturbances can occur as the result of the administration of anticancer agents in the patient with decreased kidney function. These patients are prone to developing hyponatremia, hyperkalemia and other metabolic abnormalities because of a decreased glomerular filtration rate. Therefore, all electrolytes, minerals and acid base status should be checked at baseline and before each administration of chemotherapeutic agents. Moreover, studies on patients on kidney replacement therapy are very limited and only single cases or small case series have been published. Therefore, clinical therapeutical decisions in cancer patients with decreased function should be made by multidisciplinary teams constituted of medical oncologists, nephrologists and other specialists. Onconephrology is an evolving and expanding subspecialty. It is crucial to consider anticancer drug treatment in these patients and offer them a chance to be treated effectively. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Structures for quality assurance and measurements for kidney replacement therapies: A multinational study from the ISN‐GKHA.

Author

Ekrikpo, Udeme E., Davidson, Bianca, Calice‐Silva, Viviane, Karam, Sabine, Osman, Mohamed A., Arruebo, Silvia, Caskey, Fergus J., Damster, Sandrine, Donner, Jo‐Ann, Jha, Vivekanand, Levin, Adeera, Nangaku, Masaomi, Saad, Syed, Tonelli, Marcello, Ye, Feng, Okpechi, Ikechi G., Bello, Aminu K., and Johnson, David W.

Subjects
RENAL replacement therapy, QUALITY assurance standards, WATER quality monitoring, KIDNEY failure, PERITONEAL dialysis
Abstract

Aim: Optimal care for patients with kidney failure reduces the risks of adverse health outcomes, including cardiovascular events and death. We evaluated data from the third iteration of the International Society of Nephrology Global Kidney Health Atlas (ISN‐GKHA) to assess the capacity for quality service delivery for kidney failure care across countries and regions. Method: We explored the quality of kidney failure care delivery and the monitoring of quality indicators from data provided by an international survey of stakeholders from countries affiliated with the ISN from July to September 2022. Results: One hundred and sixty seven countries participated in the survey, representing about 97.4% of the world's population. In countries where haemodialysis (HD) was available, 81% (n = 134) provided standard HD sessions (three times weekly for 3–4 h per session) to patients. Among countries with peritoneal dialysis (PD) services, 61% (n = 101) were able to provide standard PD care (3–4 exchanges per day). In high‐income countries, 98% (n = 62) reported that >75% of centers regularly monitored dialysis water quality for bacteria compared to 28% (n = 5) of low‐income countries (LICs). Capacity to monitor the administration of immunosuppression drugs was generally available in 21% (n = 4) of LICs, compared to 90% (n = 57) of high‐income countries. There was significant variability between and within regions and country income groups in reporting the quality of services utilized for kidney replacement therapies. Conclusion: Quality assurance standards on diagnostic and treatment tools were variable and particularly infrequent in LICs. Standardization of delivered care is essential for improving outcomes for people with kidney failure. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus

Author

Guillo, Lucas, Delanaye, Pierre, Flamant, Martin, Figueres, Lucile, Karam, Sabine, Lemoine, Sandrine, Benezech, Alban, Pelletier, Anne-Laure, Amiot, Aurélien, Caron, Bénédicte, Stefanescu, Carmen, Boschetti, Gilles, Bouguen, Guillaume, Rahier, Jean-François, Gornet, Jean-Marc, Hugot, Jean-Pierre, Bonnet, Joëlle, Vuitton, Lucine, Nachury, Maria, Vidon, Mathias, Uzzan, Mathieu, Serrero, Mélanie, Dib, Nina, Seksik, Philippe, Hebuterne, Xavier, Bertocchio, Jean-Philippe, Mariat, Christophe, and Peyrin-Biroulet, Laurent

Published
2022
Full Text
View/download PDF

16. Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology

Author

Herrmann, Sandra M., Abudayyeh, Ala, Gupta, Shruti, Gudsoorkar, Prakash, Klomjit, Nattawat, Motwani, Shveta S., Karam, Sabine, Costa E Silva, Verônica T., Khalid, Sheikh B., Anand, Shuchi, Kala, Jaya, Leaf, David E., Murakami, Naoka, Rashidi, Arash, Wanchoo, Rimda, and Kitchlu, Abhijat

Abstract

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer and are now the backbone of therapy for several malignancies. However, ICIs can cause a spectrum of kidney immune-related adverse events including acute kidney injury (AKI), most commonly manifesting as acute interstitial nephritis (AIN), although glomerular disease and electrolyte disturbances have also been reported. In this position statement by the American Society of Onco-nephrology (ASON), we summarize the incidence and risk factors for ICI-AKI, pathophysiological mechanisms, and clinicopathologic features of ICI-AKI. We also discuss novel diagnostic approaches and promising biomarkers for ICI-AKI. From expert panel consensus, we provide clinical practice points for the initial assessment and diagnosis of ICI-AKI, management and immunosuppressive therapy, and consideration for rechallenge with ICI following AKI episodes. In addition, we explore ICI use in special populations, such as kidney transplant recipients, and propose key areas of focus for future research and clinical investigation.

Published
2025
Full Text
View/download PDF

19. WCN24-1517 DEVELOPMENT OF THE “HOW TO CREATE A YOUNG NEPHROLOGISTS’ COMMITTEE/SOCIETY” TOOLKIT: AN ISN YOUNG NEPHROLOGISTS COMMITTEE PROJECT

Author

Bulanov, Nikolay, primary, AlShamsi, Iman, additional, Cambier, Alexandra, additional, Chávez-Iñiguez, Jonathan Samuel, additional, Gallardo, Miguel, additional, Qayyum, Ahad, additional, Shah, Anim, additional, Wainstein, Marina, additional, Karam, Sabine, additional, and Davidson, Bianca, additional

Published
2024
Full Text
View/download PDF

20. WCN24-907 Long-term cardiovascular outcomes in children and adolescents with hypertension: A population-based, propensity-matched cohort study

Author

Robinson, Cal, primary, Jeyakumar, Nivethika, additional, Smith, Graham, additional, Birken, Catherine, additional, Dart, Allison, additional, Dionne, Janis, additional, Garg, Anika, additional, Kandasamy, Sujane, additional, Karam, Sabine, additional, Marjerrison, Stacey, additional, South, Andrew, additional, Thabane, Lehana, additional, Wahi, Gita, additional, Zappitelli, Michael, additional, and Chanchlani, Rahul, additional

Published
2024
Full Text
View/download PDF

21. WCN24-758 RECOGNITION OF LOCAL INVESTIGATORS IN AUTHORSHIP OF COLLABORATIVE KIDNEY RESEARCH CONDUCTED IN LOW- AND LOWERMIDDLE INCOME COUNTRIES

Author

Wijewickrama, Eranga, primary, Chanchlani, Rahul, additional, Wong, Michelle, additional, Kumar, Vivek, additional, Karam, Sabine, additional, Chen, Titi, additional, Erikpo, Udeme, additional, Tannor, Elliot, additional, Calice-Silva, Viviane, additional, Anandh, Urmila, additional, Bajpai, Divya, additional, Abdul Hafidz, Muhamed Iqbal, additional, Tian, Amanda, additional, Opare-Addo, Priscilla, additional, Edeki, Imuetinyan, additional, and Kalyesubula, Robert, additional

Published
2024
Full Text
View/download PDF

22. WCN24-718 Women Nephrologists and Conferences: Exploring the Challenges and Limitations in Participation

Author

Meena, Priti, primary, Calice-Silva, Viviane, additional, Karam, Sabine, additional, Arellano-Mendez, Denisse, additional, Shankar, Mythri, additional, Bek, Sibel Gokcay, additional, Tomacruz Amante, Isabelle Dominique, additional, Yadla, Manjusha, additional, Mohan, Krithika, additional, Bajpai, Divya, additional, Java, Anuja, additional, SOKI, KHALIDA B., additional, and Arce-Amaré, Fernanda, additional

Published
2024
Full Text
View/download PDF

24. A toolkit for ISN’s registry initiative, SharE-RR

Author

Pippias, Maria, primary, Abeysekera, Rajitha A., additional, Arruebo, Silvia, additional, Davids, M. Razeen, additional, Damster, Sandrine, additional, Gonzales-Bedat, Maria C., additional, Hanafusa, Norio, additional, Hoshino, Junichi, additional, Hradsky, Anne, additional, Irish, Georgina L., additional, Jager, Kitty J., additional, Karam, Sabine, additional, Kumar, Vivek, additional, McDonald, Stephen P., additional, Rosa-Diez, Guillermo J., additional, Tannor, Elliot K., additional, Wetmore, James B., additional, and Caskey, Fergus J., additional

Published
2024
Full Text
View/download PDF

25. Challenges to Implementing Environmentally Sustainable Kidney Care in LMICs: An Opinion Piece

Author

Bajpai, Divya, primary, Hailu, Workagegnehu, additional, Bagasha, Peace, additional, Chika, Onu Ugochi, additional, Hafiz, Ehab, additional, Tannor, Elliot Koranteng, additional, Wijewickrama, Eranga, additional, Kalyesubula, Robert, additional, Karam, Sabine, additional, Calice-Silva, Viviane, additional, Ethier, Isabelle, additional, and Sandal, Shaifali, additional

Published
2024
Full Text
View/download PDF

30. Nurturing Global Leadership, Advocacy, Research, and Collegiality: The Unique Experience of The International Society of Nephrology Emerging Leaders Program

Author

Karam, Sabine, primary, Abdul Hafidz, Muhammad Iqbal, additional, Calice-Silva, Viviane, additional, Chen, Titi, additional, Dupuis, Sophie, additional, Ekrikpo, Udeme E., additional, Francis, Anna, additional, Jha, Vivekanand, additional, Kalyesubula, Robert, additional, Kumar, Vivek, additional, Nakhoul, Georges, additional, Pereira-Kamath, Nikhil, additional, Tannor, Elliot K., additional, Tran, Anh, additional, Wijewickrama, Eranga, additional, Wong, Michelle M.Y., additional, and Chanchlani, Rahul, additional

Published
2023
Full Text
View/download PDF

32. Contributors

Author

Abudayyeh, Ala, primary, Angelo, Joseph R., additional, Bassil, Claude, additional, Batuman, Vecihi, additional, J., John, additional, S., Andrew, additional, T., Brendan, additional, C., Juan, additional, Chang, Anthony, additional, Chen, Sheldon, additional, P., Eric, additional, Cosmai, Laura, additional, Desai, Vidhi, additional, E., Marcia, additional, Gupta, Mohit, additional, W., Kevin, additional, Gallieni, Maurizio, additional, Gautam-Goyal, Pranisha, additional, Glezerman, Ilya, additional, S., Vijay, additional, Gutgarts, Victoria, additional, Heemann, Uwe, additional, Herlitz, Leal, additional, Hingorani, Sangeeta, additional, J., Jonathan, additional, L., Jean, additional, L., Susie, additional, A., Colin, additional, Jaffer, Insara, additional, D., Kenar, additional, Joseph, Catherine, additional, Kala, Jaya, additional, Karam, Sabine, additional, Kemmner, Stefan, additional, F., Sana, additional, Kitchlu, Abhijat, additional, Lahoti, Amit, additional, L., Benjamin, additional, Latcha, Sheron, additional, L., Wai, additional, L., Randy, additional, Madan, Niti, additional, Malhotra, Prashant, additional, Mollee, Peter, additional, A., Mark, additional, M., Phillip, additional, Delanaye, Pierre, additional, Porta, Camillo, additional, Radhakrishnan, Jai, additional, Rastegar, Mandana, additional, F., Robert, additional, L., Danielle, additional, A., Joshua, additional, Shankaranarayanan, Divya, additional, Sawinski, Deirdre, additional, Selamet, Umut, additional, C., Anushree, additional, Sinnakirouchenan, Ramapriya, additional, Sprangers, Ben, additional, Thakkar, Jyotsana, additional, Turner, Jeffrey, additional, Vasudev, Brahm, additional, R., Dia, additional, Wanchoo, Rimda, additional, M., Brendan, additional, H., Robert, additional, Wong, Germaine, additional, and Temiz, Gökhan, additional

Published
2020
Full Text
View/download PDF

35. Capacity for the management of kidney failure in the International Society of Nephrology Middle East region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

Author

Karam, Sabine, Amouzegar, Atefeh, Alshamsi, Iman Rashed, Al Ghamdi, Saeed M.G., Anwar, Siddiq, Ghnaimat, Mohammad, Saeed, Bassam, Arruebo, Silvia, Bello, Aminu K., Caskey, Fergus J., Damster, Sandrine, Donner, Jo-Ann, Jha, Vivekanand, Johnson, David W., Levin, Adeera, Malik, Charu, Nangaku, Masaomi, Okpechi, Ikechi G., Tonelli, Marcello, Ye, Feng, Abu-Alfa, Ali K., Savaj, Shokoufeh, Abou-Jaoudeh, Pauline, Al Hussain, Turki, Al Salmi, Issa Salim Amur, Alrukhaimi, Mona, Alyousef, Anas, Bahous, Sola Aoun, Cai, Guangyan, Cheikh Hassan, Hicham I., Cho, Yeoungjee, Davids, M. Razeen, Davison, Sara N., Diongole, Hassane M., Divyaveer, Smita, Ekrikpo, Udeme E., Ethier, Isabelle, Fung, Winston Wing-Shing, Ghimire, Anukul, Hooman, Nakysa, Houston, Ghenette, Htay, Htay, Ibrahim, Kwaifa Salihu, Irish, Georgina, Jindal, Kailash, Kelly, Dearbhla M., Lalji, Rowena, Mitwali, Ahmed, Mortazavi, Mojgan, Nalado, Aisha M., Neuen, Brendon L., Olanrewaju, Timothy O., Osman, Mohamed A., Ossareh, Shahrzad, Petrova, Anna, Riaz, Parnian, Saad, Syed, Sakajiki, Aminu Muhammad, See, Emily, Sozio, Stephen M., Tiv, Sophanny, Tungsanga, Somkanya, Viecelli, Andrea, Wainstein, Marina, Wannous, Hala, Yeung, Emily K., and Zaidi, Deenaz

Abstract

The highest financial and symptom burdens and the lowest health-related quality-of-life scores are seen in people with kidney failure. A total of 11 countries in the International Society of Nephrology (ISN) Middle East region responded to the ISN-Global Kidney Health Atlas. The prevalence of chronic kidney disease (CKD) in the region ranged from 4.9% in Yemen to 12.2% in Lebanon, whereas prevalence of kidney failure treated with dialysis or transplantation ranged from 152 per million population (pmp) in the United Arab Emirates to 869 pmp in Kuwait. Overall, the incidence of kidney transplantation was highest in Saudi Arabia (20.2 pmp) and was lowest in Oman (2.2 pmp). Chronic hemodialysis (HD) and peritoneal dialysis (PD) services were available in all countries, whereas kidney transplantation was available in most countries of the region. Public government funding that makes acute dialysis, chronic HD, chronic PD, and kidney transplantation medications free at the point of delivery was available in 54.5%, 72.7%, 54.5%, and 54.5% of countries, respectively. Conservative kidney management was available in 45% of countries. Only Oman had a CKD registry; 7 countries (64%) had dialysis registries, and 8 (73%) had kidney transplantation registries. The ISN Middle East region has a high burden of kidney disease and multiple challenges to overcome. Prevention and detection of kidney disease can be improved by the design of tailored guidelines, allocation of additional resources, improvement of early detection at all levels of care, and implementation of sustainable health information systems.

Published
2024
Full Text
View/download PDF

36. Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

Author

Lowe-Jones, Racquel, Ethier, Isabelle, Fisher, Lori-Ann, Wong, Michelle M.Y., Thompson, Stephanie, Nakhoul, Georges, Sandal, Shaifali, Chanchlani, Rahul, Davison, Sara N., Ghimire, Anukul, Jindal, Kailash, Osman, Mohamed A., Riaz, Parnian, Saad, Syed, Sozio, Stephen M., Tungsanga, Somkanya, Cambier, Alexandra, Arruebo, Silvia, Bello, Aminu K., Caskey, Fergus J., Damster, Sandrine, Donner, Jo-Ann, Jha, Vivekanand, Johnson, David W., Levin, Adeera, Malik, Charu, Nangaku, Masaomi, Okpechi, Ikechi G., Tonelli, Marcello, Ye, Feng, Parekh, Rulan S., Anand, Shuchi, Agarwal, Anil K., Amouzegar, Atefeh, Avila-Casado, Carmen, Barton, Everard N., Behera, Suman, Felix, Melvin Bonilla, Cerda, Jorge, Cho, Yeoungjee, Cybulsky, Andrey V., Davids, M. Razeen, Diaz-González de Ferris, María Esther, Diongole, Hassane M., Divyaveer, Smita, Ekrikpo, Udeme E., Fogo, Agnes B., Friedman, David, Wing-Shing Fung, Winston, Furth, Susan L., Gill, John, Houston, Ghenette, Hsiao, Li-Li, Hsu, Chi-yuan, Htay, Htay, Ibrahim, Kwaifa Salihu, Irish, Georgina, Karam, Sabine, Kelly, Dearbhla M., Lalji, Rowena, Lerma, Edgar V., Mac-Way, Fabrice, Macedo, Etienne, Mohammed, Hassina, Nair, Devika, Nalado, Aisha M., Neuen, Brendon L., Olanrewaju, Timothy O., Vela Parada, Xavier Fernanco, Pecoits-Filho, Roberto, Petrova, Anna, Prasad, Bhanu, Radix, Lisa, Raina, Rupesh, Ullur, Avinash Rao, Rosner, Mitchell H., Sakajiki, Aminu Muhammad, See, Emily, Seshan, Surya V., Teitelbaum, Isaac, Thomas, Ian, Tiv, Sophanny, Trask, Michele, Vachharajani, Tushar J., Viecelli, Andrea, Wainstein, Marina, Walsh, Michael, Wyatt, Christina, Yeates, Karen, Yeung, Emily K., Young-Peart, Sandrica, and Zaidi, Deenaz

Abstract

The International Society of Nephrology Global Kidney Health Atlas charts the availability and capacity of kidney care globally. In the North America and the Caribbean region, the Atlas can identify opportunities for kidney care improvement, particularly in Caribbean countries where structures for systematic data collection are lacking. In this third iteration, respondents from 12 of 18 countries from the region reported a 2-fold higher than global median prevalence of dialysis and transplantation, and a 3-fold higher than global median prevalence of dialysis centers. The peritoneal dialysis prevalence was lower than the global median, and transplantation data were missing from 6 of the 10 Caribbean countries. Government-funded payments predominated for dialysis modalities, with greater heterogeneity in transplantation payor mix. Services for chronic kidney disease, such as monitoring of anemia and blood pressure, and diagnostic capability relying on serum creatinine and urinalyses were universally available. Notable exceptions in Caribbean countries included non-calcium-based phosphate binders and kidney biopsy services. Personnel shortages were reported across the region. Kidney failure was identified as a governmental priority more commonly than was chronic kidney disease or acute kidney injury. In this generally affluent region, patients have better access to kidney replacement therapy and chronic kidney disease–related services than in much of the world. Yet clear heterogeneity exists, especially among the Caribbean countries struggling with dialysis and personnel capacity. Important steps to improve kidney care in the region include increased emphasis on preventive care, a focus on home-based modalities and transplantation, and solutions to train and retain specialized allied health professionals.

Published
2024
Full Text
View/download PDF

42. Social, political and legal determinants of kidney health: Perspectives from lower- and middle-income countries with a focus on India

Author

Anandh, Urmila, Meena, Priti, Karam, Sabine, Luyckx, Valerie, and University of Zurich

Subjects
610 Medicine & health, 10060 Epidemiology, Biostatistics and Prevention Institute (EBPI)
Abstract

The social determinants of health (SDoH) are the non-medical factors that influence kidney health outcomes directly or indirectly in a substantial manner and include conditions in which people are born, grow, work, live, and age. Many such challenges in lower- and middle- income countries have an unfavourable impact on kidney health. These conditions potentially influence economic policies and systems, development agendas, social norms, social policies, and political systems. In addition, many political and legal factors also determine and modify the ultimate outcome in patients with kidney disease. Legal factors that ensure universal health care, promote gender and racial equality, prevent malpractices and regulate strict laws in the field of kidney transplantation are the paramount determinants for the provision of necessary kidney care. Converging lines of evidence have supported the impact of social variables such as socioeconomic resources, social inclusion, housing conditions, educational attainment, and financial status on kidney health, particularly affect vulnerable and disadvantaged groups and result in challenges in kidney care delivery. Furthermore, the climate is an important SDoH that plays a crucial role in the occurrence, prevalence, and progression of kidney diseases as highlighted by the presence of higher prevalence of chronic kidney disease in hot tropical countries. The rising incidence of water and vector-borne diseases causing acute kidney injury is another consequence of disruptive environmental and climate change which is detrimental to kidney health. Political risk factors such as conflict also have a devastating influence on kidney health. The relationship between SDoH and kidney health outcomes requires more clarity. Gaps in the current knowledge need to be identified to inform the development of appropriate interventions to address upstream socio-economic risk factors for kidney disease.

Published
2022
Full Text
View/download PDF

43. Access to and barriers to access for essential medicines in nephrology and related non-communicable diseases: a scoping review protocol

Author

Wong, Michelle, Calice-Silva, Viviane, Tannor, Elliot, Nakhoul, Georges, Kumar, Vivek, Hafidz, Muhammad, Chanchlani, Rahul, Chen, Titi, Ekrikpo, Udeme, Francis, Anna, Kalyesubula, Robert, Karam, Sabine, Pereira-Kamath, Nikhil, Wijewickrama, Eranga, Sanger, Stephanie, Vanhonsebrouck, Pauline, and Jha, Vivekanand

Subjects
access, Medicine and Health Sciences, nephrology, essential medicines
Abstract

Access to essential medicines for treatment of non-communicable diseases (NCDs) is lacking in low- and low-middle income countries. In nephrology, access to essential medicines is especially important to reduce risk of chronic kidney disease (CKD) progression, as kidney replacement therapy is unavailable or cost-prohibitive in many regions of the world. As part of the International Society of Nephrology (ISN) Emerging Leaders Program’s mandate to improve health promotion and access to prevention and management of kidney diseases globally, this scoping review aims to understand the extent of evidence regarding: 1) access to essential medicines for CKD and related NCDs, 2) barriers to access, and 3) interventions to improve access.

Published
2022
Full Text
View/download PDF

46. NephroConnect: Patterns, Preferences, Barriers, and Potentials in the Global Nephrology Community’s Social Media Landscape

Author

Bek, Sibel G., Karam, Sabine, Murphy, Daniel P., Moura-Neto, José A., Balcı, Sibel, Gawad, Mohammed A., Claure-Del Granado, Rolando, Parikh, Namrata, Gopal, Basu, Yadla, Manju, Tannor, Elliot, Nlandu, Yannick, Turgut, Didem, Parada, Xavier V., Akl, Ahmed, Soares dos Santos Junior, Augusto Cesar, Arce-Amare, Fernanda, Anandh, Urmila, Lerma, Edgar, and Baharani, Jyoti

Published
2024
Full Text
View/download PDF

48. Challenges and Opportunities of a Virtual Nephrology Meeting: The ISN World Congress of Nephrology 2021

Author

Claure-Del Granado, Rolando, primary, Anandh, Urmila, additional, Lerma, Edgar, additional, Conjeevaram, Arvind, additional, Arce-Amaré, Fernanda, additional, dos Santos, Augusto Cesar Soares, additional, Basu, Gopal, additional, Bek, Sibel, additional, Dhakal, Ajaya Kumar, additional, Gawad, Mohammed Abdel, additional, AkL, Ahmed, additional, Turgut, Didem, additional, Karam, Sabine, additional, Bajpai, Divya, additional, Pecoits-Filho, Roberto, additional, and Parikh, Namrata, additional

Published
2022
Full Text
View/download PDF

49. Access to and Barriers to Access for Essential Medicines in Nephrology and Related Non-Communicable Diseases: A Scoping Review Protocol

Author

Wong, Michelle Mon Yee, primary, Calice-Silva, Viviane, additional, Tannor, Elliot K., additional, Nakoul, Georges, additional, Kumar, Vivek, additional, Hafidz, Muhammad Iqbal Abdul, additional, Chanchlani, Rahul, additional, Chen, Titi, additional, Ekrikpo, Udeme E., additional, Francis, Anna, additional, Kalyesubula, Robert, additional, Karam, Sabine, additional, Pereira-Kamath, Nikhil, additional, Wijewickrama, Eranga, additional, Sanger, Stephanie, additional, and Jha, Vivekanand, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results